Live Breaking News & Updates on European commmission
Stay updated with breaking news from European commmission. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drug Shortages Affected 111 Products In The UK Thisyear But The Outlook For 2024 May Be Better menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Early Access to BioCryst’s Berotralstat Granted for HAE Patients in France News Provided By Share This Article For investors and media only RESEARCH TRIANGLE PARK, N.C., March 11, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the French National Agency for Medicines and Health Products Safety (ANSM) has granted an Autorisation Temporaire d'Utilisation de cohorte (cohort ATU), or Temporary Authorization for Use, for the use of berotralstat to prevent attacks of hereditary angioedema (HAE) in appropriate patients aged 12 and older. This cohort ATU allows patients with HAE in France to receive treatment with berotralstat before the drug is granted marketing authorization by the European Commmission (EC).